Researchers find a ‘hidden pocket’ to target nuclear receptors (IMAGE)
Caption
Published today in Nature Communications, first author Andrew Huber, PhD, corresponding author Taosheng Chen, PhD, and second author Wenwei Lin, PhD, St. Jude Department of Chemical Biology and Therapeutics, uncovered a hidden binding pocket on the pregnane X receptor (PXR), paving the way for selective PROTAC therapies that target nuclear receptors while minimizing off-target effects.
Credit
St. Jude Children's Research Hospital
Usage Restrictions
No cropping
License
Original content